By: IPP Bureau
Last updated : October 07, 2025 6:03 pm
New offering to debut at the 32nd ESGCT Congress, October 7–10, 2025, in Seville, Spain
PromoCell a leading global manufacturer of primary human cells and specialized cell culture media for biomedical research, has announced its entry into the Good Manufacturing Practice (GMP) field.
The company will debut its Custom GMP Cell Culture Media Services at the 32nd European Society of Gene and Cell Therapy (ESGCT) Congress in Seville, Spain, introducing a new level of quality, compliance, and customization for the cell-based therapy and regenerative medicine sectors.
PromoCell’s Custom GMP Cell Culture Media Services are designed to bridge the critical gap between research and clinical applications. The company now offers Excipient GMP-grade cell culture media manufacturing alongside comprehensive support throughout the research-to-commercialization journey. This expansion reinforces PromoCell’s mission to empower scientists with flexible, reliable, and regulatory-compliant solutions that enable seamless scaling from discovery to therapeutic manufacturing.
“We’ve observed a growing demand for advanced cell culture media in regenerative medicine and cell-based therapy,” said Dr. Irma Börcsök, CEO of PromoCell. “We are thrilled to introduce our GMP cell culture medium service portfolio to the life science community at the ESGCT Congress. This launch underscores our commitment to supporting customers at every stage — from discovery through preclinical, clinical, and commercial manufacturing. With both off-the-shelf and customized Excipient GMP-grade solutions, we’re providing service-driven offerings that meet the highest regulatory standards and empower innovation with confidence.”
“GMP-grade” is a branding term used by PromoCell to denote reagents manufactured at its Heidelberg facility under strictly controlled processes that meet rigorous product specifications and customer requirements.